Patent · US Active

Fab I inhibitors

US7790716B2 · kind B2 · utility

13Cited by

109References

3Claims

0Family size

Assignee

Affinium Pharmaceuticals, Inc. · CA

Inventors

William Henry Miller · Collegeville, US
Kenneth A. Newlander · West Chester, US
Mark A. Seefeld · Collegeville, US
Irene N. Uzinskas · Villanova, US
Walter E. DeWolf, Jr. · Glenmoore, US
Dalia R. Jakas · Norristown, US

Key dates

Filing date	Mar 12, 2009
Grant date	Sep 7, 2010
Priority date	—
Expiry date	Mar 12, 2029

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compounds of the formula (I) are disclosed which are Fab I inhibitors and are useful in the treatment of bacterial infections.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.